Impact of pharmacist-led continuous glucose monitoring program on reduction in A1c in an FQHC
Open Access
- 17 March 2025
- journal article
- Published by Elsevier in JAPhA Practice Innovations
- Vol. 2 (3)
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Partnering for Better Health: Using Continuous Glucose Monitoring and Clinical Pharmacist Collaboration to Improve Glycemic Control in Underserved Patients With Type 2 DiabetesClinical Therapeutics, 2023
- Pharmacist-driven continuous glucose monitoring in community and ambulatory care pharmacy practice: A scoping reviewJournal of the American Pharmacists Association, 2023
- 6. Glycemic Targets: Standards of Care in Diabetes—2023Diabetes Care, 2022
- The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetesJournal of the American Pharmacists Association, 2021
- Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark StudyDiabetes Technology & Therapeutics, 2021
- Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin TherapyDiabetes Spectrum, 2021
- Continuous Glucose Monitoring As a Behavior Modification ToolClinical Diabetes, 2020
- Three European Retrospective Real-World Chart Review Studies to Determine the Effectiveness of Flash Glucose Monitoring on HbA1c in Adults with Type 2 DiabetesDiabetes Therapy, 2019